151 related articles for article (PubMed ID: 35123410)
41. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
[TBL] [Abstract][Full Text] [Related]
42. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
43. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
[TBL] [Abstract][Full Text] [Related]
44. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
[TBL] [Abstract][Full Text] [Related]
45. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
[TBL] [Abstract][Full Text] [Related]
46. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study.
Lee WJ; Liu LK; Peng LN; Lin MH; Chen LK;
J Am Med Dir Assoc; 2013 Jul; 14(7):528.e1-7. PubMed ID: 23664768
[TBL] [Abstract][Full Text] [Related]
47. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.
Proestling K; Hebar A; Pruckner N; Marton E; Vinatzer U; Schreiber M
PLoS One; 2012; 7(10):e47325. PubMed ID: 23071787
[TBL] [Abstract][Full Text] [Related]
48. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
[TBL] [Abstract][Full Text] [Related]
49. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
50. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
[TBL] [Abstract][Full Text] [Related]
51. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
[TBL] [Abstract][Full Text] [Related]
52. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development.
Sousa H; Santos AM; Catarino R; Pinto D; Vasconcelos A; Lopes C; Breda E; Medeiros R
Eur J Cancer Prev; 2006 Aug; 15(4):362-6. PubMed ID: 16835507
[TBL] [Abstract][Full Text] [Related]
53. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
54. TP53 codon 72 polymorphism and risk of acute leukemia.
Dunna NR; Vure S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S; Vishnupriya S
Asian Pac J Cancer Prev; 2012; 13(1):347-50. PubMed ID: 22502699
[TBL] [Abstract][Full Text] [Related]
55. Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.
Lajin B; Alachkar A; Alhaj SA
N Am J Med Sci; 2012 May; 4(5):212-5. PubMed ID: 22655279
[TBL] [Abstract][Full Text] [Related]
56. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
[TBL] [Abstract][Full Text] [Related]
57. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms.
Ohmori Y; Nomura T; Fukushima N; Takahashi F; Iwaya T; Koeda K; Nishizuka SS;
J Surg Oncol; 2019 Dec; 120(7):1154-1161. PubMed ID: 31578743
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.
Lera L; Albala C; Sánchez H; Angel B; Hormazabal MJ; Márquez C; Arroyo P
J Frailty Aging; 2017; 6(1):12-17. PubMed ID: 28244552
[TBL] [Abstract][Full Text] [Related]
60. No association of TP53 codon 72 SNP with male infertility: a study in a Chinese population and a meta-analysis.
Chan Y; Jiang H; Ma L; Chen J; Li D; Meng Y; Luo Y; Tang W
Syst Biol Reprod Med; 2015; 61(4):222-7. PubMed ID: 25747431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
